Why Alnylam Pharmaceuticals Stock Is Sinking Today

Shares of Alnylam Pharmaceuticals (ALNY -10.09%) were sinking 9.5% lower as of 11:27 a.m. ET on Thursday after falling as much as 12.6% earlier in the day. The sell-off came after the drugmaker announced its fourth-quarter and full-year 2023 results.Alnylam reported Q4 total revenue of $439.7 million, up 31$442.9 million.The company posted a net loss in Q4 of $137.9 million, or$1.10 per share, based on generally accepted ...